Pedro Justicia-Lirio, María Tristán-Manzano, Noelia Maldonado-Pérez, Carmen Barbero-Jiménez, Marina Cortijo-Gutiérrez, Kristina Pavlovic, . . . Francisco Martín. (2024). First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas. Elsevier.
Chicago Style (17th ed.) CitationPedro Justicia-Lirio, et al. First-in-class Transactivator-free, Doxycycline-inducible IL-18-engineered CAR-T Cells for Relapsed/refractory B Cell Lymphomas. Elsevier, 2024.
MLA (9th ed.) CitationPedro Justicia-Lirio, et al. First-in-class Transactivator-free, Doxycycline-inducible IL-18-engineered CAR-T Cells for Relapsed/refractory B Cell Lymphomas. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.